Atlanta's Elite Fashion and Entertainment Consultants

Fasoracetam Memory Improvement 110958-19-5 Nootropic Powder

Fasoracetam is a research chemical of the racetam family. It is a nootropic, and has been in clinical trials for vascular dementia and attention deficit hyperactivity disorder.
Fasoracetam appears to agonize all three metabotropic glutamate receptors and has improved cognitive function in rodent studies. It is orally available and is excreted mostly unchanged via the urine.
Fasoracetam was discovered by scientists at the Japanese pharmaceutical company Nippon Shinyaku, which brought it through Phase 3 clinical trials for vascular dementia, and abandoned it due to lack of efficacy.

Scientists at Children's Hospital of Philadelphia led by Hakon Hakonarson identified fasoracetam's potential use in attention deficit hyperactivity disorder. Hakonarson started a company called neuroFix Therapeutics, LLC to try to bring the drug to market for this use; neuroFix acquired Nippon Shinyaku's clinical data as part of its efforts. neuroFix was acquired by Medgenics in 2015. Medgenics changed its name to Aevi Genomic Medicine in 2016. Clinical trials in adolescents with ADHD who also have mGluR mutations started in 2016.
Fasoracetam Dosages
Its antidepressant effects are most prominent at large doses and a standard dose has not yet been agreed upon. In human trials, 100mg a day has been given to subjects with no observed consequences, but some psychonauts use only 10mg a day sublingually.
This puts its potency level in line with nootropics like Noopept which are said to be 1000x stronger than Piracetam.
Sides Effects:
There are currently no known side effects of fasoracetam in the scientific literature, but that does not mean it is free from risks. Not only do any synthetic drugs come with risks, but anecdotal evidence in smart drug communities can tell us a few things about the drug.
For one, some anecdotal reports suggest reduction in orgasms. A specific individual has cited this effect, but seems rare and perhaps confounded with other variables.